Vernakalant

Modify Date: 2024-01-02 23:19:00

Vernakalant Structure
Vernakalant structure
Common Name Vernakalant
CAS Number 794466-70-9 Molecular Weight 349.464
Density 1.1±0.1 g/cm3 Boiling Point 479.0±45.0 °C at 760 mmHg
Molecular Formula C20H31NO4 Melting Point N/A
MSDS N/A Flash Point 243.5±28.7 °C

 Use of Vernakalant


Vernakalant(RSD-1235) is an investigational mixed ion channel blocker that can terminate acute atrial fibrillation (AF) in humans at 2 to 5 mg/kg and may be more atrial-selective than available agents; in treatment of antiarrhythmic.IC50 value:Target:

 Names

Name (3R)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.1±0.1 g/cm3
Boiling Point 479.0±45.0 °C at 760 mmHg
Molecular Formula C20H31NO4
Molecular Weight 349.464
Flash Point 243.5±28.7 °C
Exact Mass 349.225311
PSA 51.16000
LogP 2.40
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.557

 Synthetic Route

~77%

Vernakalant Structure

Vernakalant

CAS#:794466-70-9

Literature: CARDIOME PHARMA CORP. Patent: WO2006/88525 A1, 2006 ; Location in patent: Page/Page column 118; 127-128 ;

~%

Vernakalant Structure

Vernakalant

CAS#:794466-70-9

Literature: ALPHORA RESEARCH INC.; GORIN, Boris; DIXON, Craig Edward; OUDENES, Jan; BEJAN, Elena Valentina; KINSMAN, Aaron Cleveland Patent: WO2012/40846 A1, 2012 ; Location in patent: Page/Page column 22-23 ;

~%

Vernakalant Structure

Vernakalant

CAS#:794466-70-9

Literature: ASTELLAS PHARMA INC. Patent: WO2006/75778 A1, 2006 ; Location in patent: Page/Page column 26-28 ;

~%

Vernakalant Structure

Vernakalant

CAS#:794466-70-9

Literature: Limanto, John; Ashley, Eric R.; Yin, Jingjun; Beutner, Gregory L.; Grau, Brendan T.; Kassim, Amude M.; Kim, Mary M.; Klapars, Artis; Liu, Zhijian; Strotman, Hallena R.; Truppo, Matthew D. Organic Letters, 2014 , vol. 16, # 10 p. 2716 - 2719

~%

Vernakalant Structure

Vernakalant

CAS#:794466-70-9

Literature: Limanto, John; Ashley, Eric R.; Yin, Jingjun; Beutner, Gregory L.; Grau, Brendan T.; Kassim, Amude M.; Kim, Mary M.; Klapars, Artis; Liu, Zhijian; Strotman, Hallena R.; Truppo, Matthew D. Organic Letters, 2014 , vol. 16, # 10 p. 2716 - 2719

~%

Vernakalant Structure

Vernakalant

CAS#:794466-70-9

Literature: Limanto, John; Ashley, Eric R.; Yin, Jingjun; Beutner, Gregory L.; Grau, Brendan T.; Kassim, Amude M.; Kim, Mary M.; Klapars, Artis; Liu, Zhijian; Strotman, Hallena R.; Truppo, Matthew D. Organic Letters, 2014 , vol. 16, # 10 p. 2716 - 2719

~%

Vernakalant Structure

Vernakalant

CAS#:794466-70-9

Literature: CARDIOME PHARMA CORP.; ROTH, Carol, J. Patent: WO2006/138673 A2, 2006 ; Location in patent: Page/Page column 49; 74-75 ;

~%

Vernakalant Structure

Vernakalant

CAS#:794466-70-9

Literature: ALPHORA RESEARCH INC.; GORIN, Boris; DIXON, Craig Edward; OUDENES, Jan; BEJAN, Elena Valentina; KINSMAN, Aaron Cleveland Patent: WO2012/40846 A1, 2012 ; Location in patent: Page/Page column 19 ;

 Synonyms

(3R)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-3-pyrrolidinol
(1R,2R)-2-[(3R)-hydroxypyrrolidinyl]-1-(3,4-dimethoxyphenethoxy)cyclohexane
Kynapid
Vernakalant
3-Pyrrolidinol, 1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-, (3R)-
Brinavess
(1R-{2R-[2-(3,4-dimethoxyphenyl)-ethoxy]-cyclohex-2-yl})-pyrrolidin-3R-ol
(3R)-1-{(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl}pyrrolidin-3-ol
RSD 1235
(3R)-1-{(1R,2R)-2-[2-(3,4-Dimethoxyphenyl)ethoxy]cyclohexyl}-3-pyrrolidinol
1R-(2R-(2-(3,4-dimethoxy-phenyl)-ethoxy)-cyclohexyl)-pyrrolidin-3R-ol
Vernakalant [INN:BAN]
UNII-9G468C8B13
cc-484
Vernakalant [INN]
(3R)-1-{(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl}pyrrolidinol